Collaborators and Funding
Current Funding
- National Institutes of Health: “Tissue-Engineered Electronic Nerve Interfaces (TEENI)” (PI: Judy, Co-Is: Schmidt, Otto, Rinaldi; 12/1/2018 – 12/31/2022)
- National Institutes of Health: “Electrical Stimulation of Human Myocytes in Microgravity: An In Vitro Model to Evaluate Therapeutics to Counteract Muscle Wasting” (PI: Malany, Co-I: Schmidt; 9/1/2018 – 8/31/2022)
- National Institutes of Health: “Combination of Secretome from Electrically Stimulated ASCs and Injectable ECM Scaffolds as Potential SCI Therapy” (PI: Schmidt, Co-Is: March, Patrick; 12/1/2018 – 11/30/2020)
- National Institutes of Health: “Engineering Tissue Mimics to Investigate Congenital Heart Disease” (Co-PI: Schmidt, Co-PI: Kasahara; 9/1/2016 – 1/31/2020)
- DARPA: “Tissue-Engineered Electronic Nerve Interfaces (TEENI)” (PI: Judy, Co-Is: Schmidt, Otto; 10/01/2015 – 9/15/2018)
- National Science Foundation: “Harnessing the Power of Apoptosis to Create Regenerative Acellular Biologic Scaffolds” (PI: Schmidt; 8/1/2016 – 7/31/2019)
- DARPA: “Tissue-Engineered Electronic Nerve Interfaces (TEENI)” (PI: Judy, Co-Is: Schmidt, Otto; 10/01/2015 – 3/31/2019)
Recent Past Funding
- National Institutes of Health: “Engineering In Vitro ECM Test Beds to Mimic Injury” (PI: Schmidt; 2/01/2016 – 1/31/2019)
- Conquer Paralysis Now (CPN) Challenge (Sam Schmidt Foundation): “A new injectable matrix to maximize Schwann cell transplantation efficacy following spinal cord injury” (PI: Bunge, Co-I; Schmidt; 12/1/2016 – 11/30/2018)
- The National Institutes of Health: “Magnetically Templated Regeneration Scaffolds for Nerve Injury Repair” (PI: Rinaldi, Co-I: Schmidt; 7/01/2015 – 6/30/2018)
- National Science Foundation: “Development of Multiferroic Nanocomposites for 3D Electroactive Cell Scaffolds” (PI: Andrew, Co-PI: Schmidt; 7/15/2014- 6/30/2018)
- UF Opportunity Fund: “Engineering Tissue Mimics to Investigate Congenital Heart Disease” (PI: Schmidt, Co-I: Kasahara; 5/01/2015 – 4/30/2017)
- National Science Foundation: “Hydrogels and Oligonucleotide Hybridizaton for Sustained Delivery of Small Molecule Therapeutics” (PI: Schmidt, Co-PI: Ellington; 8/1/2012 – 7/31/2016)
Current Collaborators
- Dr. Josephine Allen, Materials Science and Engineering, University of Florida
- Dr. Kyle Allen, Biomedical Engineering, University of Florida
- Dr. Jenny Andrew, Materials Science and Engineering, University of Florida
- Dr. Prodip Bose, Physiological Sciences, Malcom Randal VA Medical Center
- Dr. Mary Bunge, Miami Project to Cure Paralysis, University of Miami
- Dr. Jack Judy, Electrical Engineering, University of Florida
- Dr. Hideko Kasahara, Physiology and Functional Genomics, University of Florida
- Dr. Kevin Otto, Biomedical Engineering, University of Florida
- Dr. Carlos Rinaldi, Biomedical Engineering, University of Florida
Previous Collaborators
- Dr. Shaochen Chen, NanoEngineering, University of California, San Diego
- Dr. Andrew Ellington, Biochemistry, UT-Austin
- Dr. Aaron Goldstein, Chemical Engineering, Virginia Tech
- Dr. Raymond Grill, The University of Texas Health Science Center at Houston
- Dr. Benjamin Harris, Institute for Regenerative Medicine, Wake Forest
- Dr. Silvia Luebben, TDA Research, Inc., Wheat Ridge, Colorado
- Dr. Nicholas Peppas, Biomedical Engineering, UT-Austin
- Dr. Pengyu Ren, Biomedical Engineering, UT-Austin
- Dr. Tim Schallert, Department of Psychology and Institute for Neuroscience, UT-Austin
- Dr. Jason Shear, Chemistry, UT-Austin
- Dr. Dionicio Siegel, Chemistry and Biochemistry, UT-Austin
- Dr. Jerry Silver, Neurosciences, Case Western Reserve
- Dr. Laura Suggs, Biomedical Engineering, UT-Austin
- Dr. Muhammad Zaman, Biomedical Engineering, Boston University
Previous Funding Sources
- Anderson Charitable Foundation
- AxoGen, Inc., Alachua, FL
- TDA Research, Inc., Wheat Ridge, Colorado
- Alafair Biosciences
- MicroFab Corporation, Dallas, TX [NIH R44 NS040625]
- Zimmer (Biologics Division), Austin, TX
- LifeCell Corporation, Branchburg, NJ
